DK1868625T3 - Forbedret fremgangsmåde til fremstilling af ginkgo-ekstrakter med et lavt indhold af 4'-O-methylpyridoxin og/eller biflavoner - Google Patents

Forbedret fremgangsmåde til fremstilling af ginkgo-ekstrakter med et lavt indhold af 4'-O-methylpyridoxin og/eller biflavoner

Info

Publication number
DK1868625T3
DK1868625T3 DK06742753T DK06742753T DK1868625T3 DK 1868625 T3 DK1868625 T3 DK 1868625T3 DK 06742753 T DK06742753 T DK 06742753T DK 06742753 T DK06742753 T DK 06742753T DK 1868625 T3 DK1868625 T3 DK 1868625T3
Authority
DK
Denmark
Prior art keywords
methylpyridoxine
biflavones
preparation
low
improved process
Prior art date
Application number
DK06742753T
Other languages
Danish (da)
English (en)
Inventor
Clemens Erdelmeier
Hermann Hauer
Egon Koch
Friedrich Lang
Original Assignee
Schwabe Willmar Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwabe Willmar Gmbh & Co filed Critical Schwabe Willmar Gmbh & Co
Application granted granted Critical
Publication of DK1868625T3 publication Critical patent/DK1868625T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK06742753T 2005-05-03 2006-04-28 Forbedret fremgangsmåde til fremstilling af ginkgo-ekstrakter med et lavt indhold af 4'-O-methylpyridoxin og/eller biflavoner DK1868625T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005020685 2005-05-03
DE102005061948A DE102005061948A1 (de) 2005-05-03 2005-12-23 Verbessertes Verfahren zur Herstellung von 4'-O-Methylpyridoxin- und/oder Biflavon-armen Ginkgoextrakten
PCT/EP2006/004029 WO2006117169A1 (en) 2005-05-03 2006-04-28 Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones

Publications (1)

Publication Number Publication Date
DK1868625T3 true DK1868625T3 (da) 2008-11-10

Family

ID=36693938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06742753T DK1868625T3 (da) 2005-05-03 2006-04-28 Forbedret fremgangsmåde til fremstilling af ginkgo-ekstrakter med et lavt indhold af 4'-O-methylpyridoxin og/eller biflavoner

Country Status (26)

Country Link
US (2) US20060251746A1 (de)
EP (1) EP1868625B1 (de)
JP (2) JP4304230B2 (de)
KR (1) KR100933721B1 (de)
CN (2) CN101175505A (de)
AR (1) AR054270A1 (de)
AT (1) ATE401903T1 (de)
AU (1) AU2006243378B2 (de)
BR (1) BRPI0611093B1 (de)
CA (1) CA2606843C (de)
DE (2) DE102005061948A1 (de)
DK (1) DK1868625T3 (de)
DO (1) DOP2006000091A (de)
ES (1) ES2310408T3 (de)
JO (1) JO2523B1 (de)
MX (1) MX2007013398A (de)
MY (1) MY143650A (de)
NZ (1) NZ563818A (de)
PE (1) PE20061296A1 (de)
PL (1) PL1868625T3 (de)
PT (1) PT1868625E (de)
RU (1) RU2367459C2 (de)
SI (1) SI1868625T1 (de)
TW (1) TWI376230B (de)
UA (1) UA84519C2 (de)
WO (1) WO2006117169A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE041715T2 (hu) 2007-12-21 2019-05-28 Dr Willmar Schwabe Gmbh & Co Kg Ginkgo biloba levél-kivonat alkalmazása
EP2494979B1 (de) 2011-03-04 2019-03-27 Dr. Willmar Schwabe GmbH & Co. KG Verwendung von Extrakten aus Blättern von Ginkgo biloba zur Prävention und Therapie von Komplikationen nach operativer Arteriosklerose-Behandlung sowie von Folgeerscheinungen der Arteriosklerose
MX341428B (es) 2011-04-27 2016-08-18 Dr Willmar Schwabe Gmbh & Co Kg Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.
DE102014202318B4 (de) * 2014-02-10 2016-10-06 Dr. Willmar Schwabe Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Ginkgoextrakten
CN103919768B (zh) * 2014-03-30 2016-03-16 吴静 一种含有异银杏双黄酮和白果内酯的药物组合物及其制剂
CN107509997B (zh) * 2017-09-08 2021-02-26 南京林业大学 一种基于内源糖苷酶酶解结合树脂吸附脱除白果致毒成分的方法及其制备的产品和应用
CN107647407A (zh) * 2017-11-14 2018-02-02 宜昌东方昌绿茶业有限公司 一种从银杏茶中提取黄酮素的方法
CN113491721B (zh) * 2020-03-19 2022-05-31 江苏得乐康生物科技有限公司 一种脱除银杏叶提取物中银杏毒素的方法
CN115894424B (zh) * 2023-01-06 2023-05-12 中日友好医院(中日友好临床医学研究所) 新型双黄酮类化合物及其制备方法、药物组合物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627387B1 (fr) 1988-02-24 1992-06-05 Fabre Sa Pierre Procede d'obtention d'un extrait de feuilles de ginkgo biloba
GB8822004D0 (en) * 1988-09-20 1988-10-19 Indena Spa New extracts of ginkgo biloba & their methods of preparation
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
JP3518882B2 (ja) 1993-11-12 2004-04-12 ダイセル化学工業株式会社 イチョウエキス及びその製造法
DE19756848C2 (de) * 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
US20040076691A1 (en) * 2002-01-16 2004-04-22 David Haines Anti-inflammatory formulations
CN1251675C (zh) * 2004-02-10 2006-04-19 张正生 一种注射用银杏达莫粉针剂及其制备方法
CN100451013C (zh) * 2004-04-21 2009-01-14 徐州技源天然保健品有限公司 一种从卷柏中提取穗花杉双黄酮提取物的生产工艺

Also Published As

Publication number Publication date
ATE401903T1 (de) 2008-08-15
US8642099B2 (en) 2014-02-04
BRPI0611093B1 (pt) 2018-01-16
RU2367459C2 (ru) 2009-09-20
UA84519C2 (ru) 2008-10-27
JP4304230B2 (ja) 2009-07-29
PE20061296A1 (es) 2007-01-06
US20080286391A1 (en) 2008-11-20
CN101175505A (zh) 2008-05-07
JP2009173663A (ja) 2009-08-06
DOP2006000091A (es) 2007-01-31
CA2606843C (en) 2010-05-25
TWI376230B (en) 2012-11-11
TW200716149A (en) 2007-05-01
MX2007013398A (es) 2007-12-07
PT1868625E (pt) 2008-09-22
JP2008540354A (ja) 2008-11-20
EP1868625A1 (de) 2007-12-26
EP1868625B1 (de) 2008-07-23
KR20070112271A (ko) 2007-11-22
PL1868625T3 (pl) 2009-01-30
NZ563818A (en) 2009-11-27
ES2310408T3 (es) 2009-01-01
WO2006117169A1 (en) 2006-11-09
JO2523B1 (en) 2010-03-17
US20060251746A1 (en) 2006-11-09
CN104189025A (zh) 2014-12-10
KR100933721B1 (ko) 2009-12-24
MY143650A (en) 2011-06-30
AR054270A1 (es) 2007-06-13
AU2006243378A1 (en) 2006-11-09
DE602006001949D1 (de) 2008-09-04
BRPI0611093A2 (pt) 2010-08-10
RU2007143632A (ru) 2009-06-10
SI1868625T1 (sl) 2008-12-31
AU2006243378B2 (en) 2008-03-20
CA2606843A1 (en) 2006-11-09
DE102005061948A1 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
DK1868625T3 (da) Forbedret fremgangsmåde til fremstilling af ginkgo-ekstrakter med et lavt indhold af 4'-O-methylpyridoxin og/eller biflavoner
FR22C1027I1 (fr) Formulations stabilisant et inhibant la précipitation de compositions immunogènes
NO20200320A1 (no) Sammensetninger og fremgangsmåter for fremstilling av lite vannoppløselige medikamenter med økt stabilitet
DK1755743T3 (da) Beta-hydroxybutyrat og derivater til behandling af depression og angst
DK1771201T3 (da) Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom
DK2110135T3 (da) Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1922309T3 (da) N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1874557T3 (da) Identitetsdokument og fremgangsmåde til fremstilling deraf
DK1853271T3 (da) Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
DK1948695T3 (da) Immunogene sammensætninger og fremgangsmåder til andvendelse
DK2026819T3 (da) Forebyggelse og/eller behandling af Alzheimers sygdom
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1773361T4 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
HK1101347A1 (en) Fasudil-containing preparation and method of improving stability thereof
EE200700051A (et) Meetod 2H-kromeeni valmistamiseks ning vahehendid
DK1564203T3 (da) Ny fremgangsmåde til fremstilling af (7-methoxy-1-napthyl)acetonitril og anvendelse heraf til syntese af agomelatin
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
GB0522460D0 (en) Composition and method for the treatment of avian influenza
DK1919290T3 (da) Fremgangsmåder og produkter til behandling af sygdomme
DK1848440T3 (da) Farmaceutisk sammensætning og fremgangsmåde til regenerering af myofibre i behandlingen af muskelskader
DK1783105T3 (da) Mørtelsammensætning, fremgangsmåde til fremstilling og anvendelse deraf
EP1929881A4 (de) Emulsionszusammensetzung und verfahren zur herstellung davon
DK1812797T3 (da) Sammensætninger og fremgangsmåder til behandling og forebyggelse af hyperproliferative sygdomme